Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Alves

Showing results (41-50 of 327) with videos related to

Pageof 33
Sort By:
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|November 6, 2021
Risk of Cardiovascular and Venous Thromboembolic Events Associated With Janus Kinase Inhibitors in Rheumatoid Arthritis: A Systematic Review and Network Meta-analysisCarlos Alves, Ana Penedones, Diogo Mendes, et al.
European Journal of Clinical Pharmacology|October 7, 2022
The safety of systemic Janus kinase inhibitors in atopic dermatitis: a systematic review and network meta-analysisCarlos Alves, Ana Penedones, Diogo Mendes, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|July 30, 2014
Safety monitoring of ophthalmic biologics: a systematic review of pre- and postmarketing safety dataAna Penedones, Diogo Mendes, Carlos Alves, et al.
International Journal of Clinical Pharmacy|April 19, 2023
Topical Janus kinase inhibitors in atopic dermatitis: a safety network meta-analysisCarlos Alves, Ana Penedones, Diogo Mendes, et al.
Ophthalmic Epidemiology|July 22, 2020
A Systematic Review of Economic Studies Evaluating Ophthalmic Drugs: An Analysis of the Health-state UtilitiesInês Ribeiro, Francisco Batel Marques, Diogo Mendes, et al.
Journal of Nursing Management|April 22, 2011
Multiple drug exposure as a risk factor for the seriousness of adverse drug reactionsAna Filipa Macedo, Carlos Alves, Nuno Craveiro, et al.
The Journal of Investigative Dermatology|March 23, 2021
MMP-9 Mediates Cross-Talk between Neutrophils and Endothelial Cells in PsoriasisJosé Carlos Alves-Filho, Bruno Marcel Silva Melo, Bernhard Ryffel
Expert Opinion on Drug Safety|March 14, 2020
Spontaneous reports of hypersensitivity adverse drug reactions in Portugal: a retrospective analysisDiogo Mendes, Ana Rita Oliveira, Carlos Alves, et al.
Diabetes, Obesity & Metabolism|June 1, 2026
Efficacy and Safety of Once-Weekly and Once-Daily Basal Insulins in Type 1 Diabetes Mellitus: A Systematic Review and Network Meta-Analysis of Clinical TrialsRicardo Amaral, Beatriz Costa, Ana Penedones, et al.
Biomedicines|April 23, 2022
PI3K Signaling in Mechanisms and Treatments of Pulmonary Fibrosis Following Sepsis and Acute Lung InjuryJean Piero Margaria, Lucia Moretta, Jose Carlos Alves-Filho, et al.
Pageof 33

Showing results (41-50 of 327) with videos related to

Sort By:
Pageof 33
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|November 6, 2021
Risk of Cardiovascular and Venous Thromboembolic Events Associated With Janus Kinase Inhibitors in Rheumatoid Arthritis: A Systematic Review and Network Meta-analysisCarlos Alves, Ana Penedones, Diogo Mendes, et al.
European Journal of Clinical Pharmacology|October 7, 2022
The safety of systemic Janus kinase inhibitors in atopic dermatitis: a systematic review and network meta-analysisCarlos Alves, Ana Penedones, Diogo Mendes, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|July 30, 2014
Safety monitoring of ophthalmic biologics: a systematic review of pre- and postmarketing safety dataAna Penedones, Diogo Mendes, Carlos Alves, et al.
International Journal of Clinical Pharmacy|April 19, 2023
Topical Janus kinase inhibitors in atopic dermatitis: a safety network meta-analysisCarlos Alves, Ana Penedones, Diogo Mendes, et al.
Ophthalmic Epidemiology|July 22, 2020
A Systematic Review of Economic Studies Evaluating Ophthalmic Drugs: An Analysis of the Health-state UtilitiesInês Ribeiro, Francisco Batel Marques, Diogo Mendes, et al.
Journal of Nursing Management|April 22, 2011
Multiple drug exposure as a risk factor for the seriousness of adverse drug reactionsAna Filipa Macedo, Carlos Alves, Nuno Craveiro, et al.
The Journal of Investigative Dermatology|March 23, 2021
MMP-9 Mediates Cross-Talk between Neutrophils and Endothelial Cells in PsoriasisJosé Carlos Alves-Filho, Bruno Marcel Silva Melo, Bernhard Ryffel
Expert Opinion on Drug Safety|March 14, 2020
Spontaneous reports of hypersensitivity adverse drug reactions in Portugal: a retrospective analysisDiogo Mendes, Ana Rita Oliveira, Carlos Alves, et al.
Diabetes, Obesity & Metabolism|June 1, 2026
Efficacy and Safety of Once-Weekly and Once-Daily Basal Insulins in Type 1 Diabetes Mellitus: A Systematic Review and Network Meta-Analysis of Clinical TrialsRicardo Amaral, Beatriz Costa, Ana Penedones, et al.
Biomedicines|April 23, 2022
PI3K Signaling in Mechanisms and Treatments of Pulmonary Fibrosis Following Sepsis and Acute Lung InjuryJean Piero Margaria, Lucia Moretta, Jose Carlos Alves-Filho, et al.
Pageof 33